Treatment of faecal incontinence
AssigneeUrogene
InventorsJacques Ferte, Hugues Bienayme, Francisco Carlos Perez Martinez
Life of this patent
Estimating the term…
Abstract
Use of a compound corresponding to formula (I) in which R represents hydrogen or a group chosen from alkyl, alkylene, alkylidyne, cycloalkyl, cycloalkylene, cycloalkylidyne and —CONH2 groups, and the —COR′ and —COOR′ groups, in which R′ is chosen from alkyl, alkylene, alkylidyne, cycloalkyl, cycloalkylene and cycloalkylidyne groups, it being possible for said groups R and/or R′ to be substituted and/or interrupted with -0-, —COO—, —OCO—, —NHCO— or —CONH— functions, or a pharmaceutically acceptable salt of said compound, for obtaining a medicament for use in the treatment of faecal incontinence.
Claims8
A medicament for treatment of faecal incontinence comprising a compound corresponding to formula (I):
- in which R represents hydrogen or a group chosen from alkyl, alkylene, alkylidyne, cycloalkyl, cycloalkylene, cycloalkylidyne and —CONH2 groups, and the —COR′ and —COOR′ groups, in which R′ is chosen from alkyl, alkylene, alkylidyne, cycloalkyl, cycloalkylene and cycloalkylidyne groups, it being possible for said groups R and/or R′ to be substituted and/or interrupted with —O—, —COO—, —OOO—, —NHCO— or —CONH— functions, or a pharmaceutically acceptable salt of said compound.
Dependencies are inferred from the claim text.